Shares of Pharmaceutical Product Development Inc. (NASDAQ: PPDI) rallied more than 3% Tuesday on renewed speculation that the company could be a takeover target. Pharmaceutical Product Development, Inc., a contract research organization, provides drug discovery, development, and lifecycle management services. It operates in two segments, Clinical Development Services and Laboratory Services.
Full Disclosure: None.
